Argon Medical Devices, a manufacturer of specialty medical products, has obtained an approval from the US Food and Drug Administration (FDA) to begin marketing its OptionELITE retrievable inferior vena cava (IVC) filter with a new over-the-wire delivery technique.

According to the company, the OptionELITE filter with the new over-the-wire delivery technique allows clinicians to safely deliver the filter to a patient’s IVC by following the path of a guidewire. The guidewire helps in keeping the filter centered in the IVC upon placement.

Argon Medical Devices claims that OptionELITE is the only retrievable IVC filter that can be delivered by passing the filter’s apex over a guidewire.

The company will launch the OptionELITE filter with the new over-the-wire delivery technique at the 26th Annual International Symposium of Endovascular Therapy in Miami Beach, Florida, from 18 January to 22 January 2014.

Argon Medical Devices president George Leondis noted the company remains committed to providing best-in-class products that allow physicians to provide safe and effective therapy to the patients they treat.

"Among retrievable IVC filters, finding the right combination of features that make a filter easy to deliver, provide stability in the IVC, and make it easy to retrieve, is a key balance that few designs have achieved. Since its launch in the U.S. market the Option™ELITE has demonstrated that balance and we’re pleased to now offer it to more patients worldwide," Leondis added.

The company would also begin marketing its OptionELITE in Europe following the recent CE Mark approval.

Recently, Argon Medical Devices has obtained Health Canada approval for OptionELITE and has begun marketing the devices in the country.

Rex Medical has designed the OptionELITE retrievable IVC filter for the prevention of recurrent pulmonary embolism.